Literature DB >> 18646058

Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults.

Martyn J Parker1, Helen H G Handoll.   

Abstract

BACKGROUND: Two types of implants used for the surgical fixation of extracapsular hip fractures are cephalocondylic intramedullary nails, which are inserted into the femoral canal proximally to distally across the fracture, and extramedullary implants (e.g. the sliding hip screw).
OBJECTIVES: To compare cephalocondylic intramedullary nails with extramedullary implants for extracapsular hip fractures in adults. SEARCH STRATEGY: We searched the Cochrane Bone, Joint and Muscle Trauma Group Specialised Register (June 2007), the Cochrane Central Register of Controlled Trials (The Cochrane Library 2007, Issue 2), MEDLINE (1966 to June week 3 2007), EMBASE (1988 to 2007 Week 27), the UK National Research Register, orthopaedic journals, conference proceedings and reference lists of articles. SELECTION CRITERIA: All randomised and quasi-randomised controlled trials comparing cephalocondylic nails with extramedullary implants for extracapsular hip fractures. DATA COLLECTION AND ANALYSIS: Both authors independently assessed trial quality and extracted data. Wherever appropriate, results were pooled. MAIN
RESULTS: Predominantly older people with mainly trochanteric fractures were treated in the 36 included trials.Twenty-two trials (3871 participants) compared the Gamma nail with the sliding hip screw (SHS). The Gamma nail was associated with an increased risk of operative and later fracture of the femur and an increased reoperation rate. There were no major differences between implants in the wound infection, mortality or medical complications.Five trials (623 participants) compared the intramedullary hip screw (IMHS) with the SHS. Fracture fixation complications were more common in the IMHS group; all cases of operative and later fracture of the femur occurred in this group. Results for post-operative complications, mortality and functional outcomes were similar in the two groups. Three trials (394 participants) showed no difference in fracture fixation complications, reoperation, wound infection and length of hospital stay for proximal femoral nail (PFN) compared with the SHS. Single trials compared the Targon PF nail versus SHS (60 participants); experimental mini-invasive static intramedullary nail versus SHS (60 participants); Kuntscher-Y nail versus SHS (230 participants); Gamma nail versus Medoff sliding plate (217 participants); and PFN versus Medoff sliding plate (203 participants). These trials provided insufficient evidence to establish differences between these implants. Two trials (65 participants with reverse and transverse fractures at the level of the lesser trochanter) found intramedullary nails (Gamma nail or PFN) were associated with better intra-operative results and fewer fracture fixation complications than extramedullary implants (a 90-degree blade plate or dynamic condylar screw) for these fractures. AUTHORS'
CONCLUSIONS: Given the lower complication rate of the SHS in comparison with intramedullary nails, SHS appears superior for trochanteric fractures. Further studies are required to determine if different types of intramedullary nail produce similar results, or if intramedullary nails have advantages for selected fracture types (for example, subtrochanteric fractures).

Entities:  

Mesh:

Year:  2008        PMID: 18646058     DOI: 10.1002/14651858.CD000093.pub4

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  47 in total

1.  Short-term and long-term orthopaedic issues in patients with fragility fractures.

Authors:  Susan V Bukata; Stephen L Kates; Regis J O'Keefe
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

2.  [Treatment results after cemented hemiprosthesis for care of unstable pertrochanteric femoral fractures in the elderly].

Authors:  S Grote; F Stegmeyer; V Bogner; P Biberthaler; W Mutschler
Journal:  Unfallchirurg       Date:  2012-03       Impact factor: 1.000

3.  Comparative study of InterTAN and Dynamic Hip Screw in treatment of femoral intertrochanteric injury and wound.

Authors:  Qiang Wang; Xin Yang; Hua-Zheng He; Li-Jun Dong; De-Gang Huang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

4.  Treatment of femoral subtrochanteric fractures with proximal lateral femur locking plates.

Authors:  Sun-Jun Hu; Shi-Min Zhang; Guang-Rong Yu
Journal:  Acta Ortop Bras       Date:  2012-12       Impact factor: 0.513

5.  Prospective randomised study comparing screw versus helical blade in the treatment of low-energy trochanteric fractures.

Authors:  Richard Stern; Anne Lübbeke; Domizio Suva; Hermes Miozzari; Pierre Hoffmeyer
Journal:  Int Orthop       Date:  2011-03-10       Impact factor: 3.075

Review 6.  [Pertrochanteric femoral fractures in the elderly].

Authors:  G H Sandmann; P Biberthaler
Journal:  Unfallchirurg       Date:  2015-05       Impact factor: 1.000

7.  Which implant is better for treating reverse obliquity fractures of the proximal femur: a standard or long nail?

Authors:  Güvenir Okcu; Nadir Ozkayin; Cemil Okta; Ismet Topcu; Kemal Aktuglu
Journal:  Clin Orthop Relat Res       Date:  2013-09       Impact factor: 4.176

Review 8.  Is rotation the mode of failure in pertrochanteric fractures fixed with nails? Theoretical approach and illustrative cases.

Authors:  C Kokoroghiannis; D Vasilakos; K Zisis; G Dimitriou; E Pappa; D Evangelopoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-09-20

Review 9.  Recent aspects on outcomes in geriatric fracture patients.

Authors:  N Suhm; D Rikli; S Schaeren; P Studer; M Jakob; S L Kates
Journal:  Osteoporos Int       Date:  2010-11-06       Impact factor: 4.507

10.  Comparison of migration behavior between single and dual lag screw implants for intertrochanteric fracture fixation.

Authors:  George K Kouvidis; Mark B Sommers; Peter V Giannoudis; Pavlos G Katonis; Michael Bottlang
Journal:  J Orthop Surg Res       Date:  2009-05-18       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.